← Back to headlines
Novo Nordisk Reports Successful Late-Stage Trial for Sickle Cell Disease Therapy
Novo Nordisk has announced a successful outcome in the late-stage clinical trials for its new therapy targeting sickle cell disease, marking a significant step forward in treatment options.
20 Apr, 10:52 — 20 Apr, 10:52
Sources
Showing 1 of 1 sources
